What is SER's dilution risk score?

SER has a latest available DilutionScore record of 54/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for SER, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for SER?

DilutionWatch tracks 25 SEC filing types for SER including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect SER shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For SER, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for SER tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for SER. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

SER Dilution Risk Score: 54/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

25

📊 Float Risk

80

⚠️ Warrant Exposure

15

🔄 Convertible Debt

60

Dilution Forecast

🌥️

Advisory

Moderate dilution signals present

model est. 29%

🔁 Convertible Conversion model 40%

• Significant convertible debt: 18% potential dilution

• Elevated convertible risk (60/100)

🔄 Reverse Split model est. 30%

• 50-day avg $1.98 approaching $1 threshold

🔔 Track SER — Get forecast alerts →

Market Data

Market Cap$27.60M

Shares Outstanding25.40M

Float8.42M

Cash$23.02M

Debt$11.15M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 259.7% shares (2026Q1 vs prior)

25 institutional holders · 1.61M shares

#1 Sio Capital Management, LLC 1.00M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 318.3K shares

#3 Waverly Advisors, LLC 67.5K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest222.9K

Days to Cover8.6

% of Float2.6%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2025-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual SER Dilution Snapshot

Serina Therapeutics, Inc. (SER) has a DilutionScore of 54/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for SER: xbrl on 2025-12-31; xbrl on 2025-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.